CASP3 and prostate carcinoma: In addition, recent reports showed that the anti-cancer activity of lethal doses of protolichesterinic acid in several cancer cell lines acts via induction of apoptosis through inhibition of the expression of protein Hsp70 in prostate cancer cell lines and activation of caspase-3 in HeLa cell lines [10], [11].